Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/06/2003CN1434723A Immunostimulatory oligodeoxynucleotides
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434678A Controlling offsprings sex ratio by targeting transgenes onto the sex chromosomes
08/06/2003CN1434131A BsrBI molecular marker linked with Chinese herd lumber bone density in IL-6 gene
08/06/2003CN1434120A ST13 gene 5' terminal promotion function zone sequence and use thereof
08/06/2003CN1434116A Streptomyces ces virdocyaneus sp nov
08/06/2003CN1434115A Streptomycete albogriseus spnov
08/06/2003CN1434057A Process for preparing reversible photochromic biliprotein
08/06/2003CN1434056A Method for producing recombination human hepatitis B virus core antigen
08/06/2003CN1433675A Method for large-scale inducing plant gene mutation
08/06/2003CN1117160C Process for the preparation of recombinant proteins in E coli by high cell density fermentation
08/06/2003CN1117156C Non self-inactivating, expression targeted retroviral vectors
08/06/2003CN1117155C Novel compounds
08/06/2003CN1117154C Urokinase zymogen mutant
08/06/2003CN1117153C Thermophilic fungal expression system
08/06/2003CN1117152C Process for production L-lysine
08/06/2003CN1117151C Riboflavin synthesis in fungi
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections
08/06/2003CN1117147C PCR determining primer for zaocys dhumnade, tortoise plastron and oviductus ranae
08/05/2003US6603998 Delivery of macromolecules into cells
08/05/2003US6603553 Arrangement for detecting fluorescent light from a plurality of sample points
08/05/2003US6603065 Transformation of hereditary material of plants
08/05/2003US6603064 Nuclear male sterile plants, method of producing same and methods to restore fertility
08/05/2003US6603063 Isolated polynucleotide that encodes a pesticidally active protein of given amino acid sequence
08/05/2003US6603062 Introducing into monocotyledons nucleic acid molecules encoding a enzyme isolated from purple bacteria;
08/05/2003US6603061 Agrobacterium-mediated plant transformation method
08/05/2003US6603060 Method for regulating cell death
08/05/2003US6603059 Method of cloning animals
08/05/2003US6603057 Disruption in genomic DNA fragment; tumorigenesis and propensity to ulcerative colitis; replacement with a neomycin gene under the control of phospholipid kinase; use in prevention and treatment of tumors; drug screening
08/05/2003US6602993 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases
08/05/2003US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen
08/05/2003US6602984 Human elastase IV
08/05/2003US6602983 Polypeptide and DNA sequence corresponding to human receptor with high affinity for IgE
08/05/2003US6602977 Receptor structures
08/05/2003US6602858 Ribozyme for use as tool in genetic engineering
08/05/2003US6602857 Antisense modulation of PTP1B expression
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602850 Method of treating asthma using soluble IL-9 receptor variants
08/05/2003US6602713 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
08/05/2003US6602712 Recovering mutant bacillus; obtain bacillus, transform with vector containing protein which deactivates hemolysin, recover bacillus with deactivated hemolysin activity, propagate
08/05/2003US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid
08/05/2003US6602706 Cell comprising nucleotide sequence encoding viral gene product and recombinant nucleic acids lacking overlapping sequences; virus unable to replicate; use in treatment of genetic disorders and autoimmune diseases; antitumor agent
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602699 Recombinant DNA fragment comprising the Saccharomyces cerevisiae YNL 279 w gene promoter which, when functionally linked to a structural gene, regulates transcription thereof
08/05/2003US6602698 Human kinase proteins and polynucleotides encoding the same
08/05/2003US6602697 Process for purifying human papillomavirus virus-like particles
08/05/2003US6602696 Aspergillus tubigensis polygalacturonase
08/05/2003US6602695 Mutant enzymatic protein for use as tool in human therapeutics and diagnostics
08/05/2003US6602693 Gene encoding hyaluronan synthase
08/05/2003US6602689 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein
08/05/2003US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602686 Compositions and method for non-targeted activation of endogenous genes
08/05/2003US6602685 Compounds immobilized on a solid support; parallel screening; efficiency
08/05/2003US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602682 Kluyveromyces as a host strain
08/05/2003US6602681 Reacting enzyme, of given amino acid sequence, produced by a recombinant DNA technique from Xenopus laevis
08/05/2003US6602677 Thermostable luciferases and methods of production
08/05/2003US6602675 High throughput screening of mycelia for bioactivities or biomolecules
08/05/2003US6602672 Nucleic acid sequence; assay for distinguishing between conformational shapes and isolating infectious and noninfectious prions; neurodegenerative diseases; transgenic animals
08/05/2003US6602670 Treating tumors; obtain tissue sample, isolate nucleotide sequences, amplify nucleotide sequences, monitor nucleotide sequence concentration of marker gene, compare to control
08/05/2003US6602669 Method of detection by enhancement of silver staining
08/05/2003US6602668 For enhancing an amplification protocol
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602662 Determining whether a target nucleotide is present in a nucleic acid molecule; contacting hybridized primer with deoxyribonucleoside triphosphates, chain terminating nucleotides and a DNA polymerase; diagnosing genetic diseases
08/05/2003US6602661 Thin stacked membranes are applied to a sample; biomolecules are eluted and transferred onto each of the stacked membranes thereby producing multiple replicas
08/05/2003US6602519 Peptide factor used as replacement to steroid therapy; neutrophil migration stimulating activity; treating conditions associated with an inflammatory response of septic shock
08/05/2003US6602509 Compound and method for the prevention and/or the treatment of allergy
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003US6602499 Viral mutants for selectively killing neoplastic cells; herpes simplex virus vector; transgene encoding cytochrome P450, chemotherapeutic agent activated by cytochrome P450; viral mediated oncolysis and anticancer "suicide" gene therapy
08/05/2003US6602473 Reaction mixture contained in a tube or insert; slot for receiving the insert holding reaction fluid is made of ceramics, polymers, metals, metallic alloys, composites; resistive heater; microarray
08/05/2003CA2329259C Convection-enhanced delivery of aav vectors
08/05/2003CA2236067C Methods, apparatus and computer program products for determining quantities of nucleic acid sequences in samples
08/05/2003CA2228590C Cerebellum-derived growth factors, and uses related thereto
08/05/2003CA2202549C Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene
08/03/2003WO2003064618A2 Immune response replication in cloned animals
08/03/2003CA2474901A1 Immune response replication in cloned animals
08/01/2003CA2369970A1 Hepatitis c inhibitor tri-peptides
07/2003
07/31/2003WO2003062791A2 Detection of single nucleotide polymorphisms using planar waveguides
07/31/2003WO2003062790A2 Solid phases optimized for chemiluminescent detection
07/31/2003WO2003062472A1 Cooperative oligonucleotides
07/31/2003WO2003062471A1 Model cell systems for screening of anti-hypertrophic therapeutics
07/31/2003WO2003062467A2 Tissue rejection
07/31/2003WO2003062462A2 Method for isolating nucleic acids and protein from a single sample
07/31/2003WO2003062455A2 Zinc finger domain recognition code and uses thereof
07/31/2003WO2003062450A2 Probe correction for gene expression level detection
07/31/2003WO2003062448A2 Sqv nucleic acids and polypeptides
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062441A1 Methods for fetal dna detection and allele quantitation
07/31/2003WO2003062436A1 PROCESS FOR PREPARING CHIRAL AROMATIC α-HYDROXY KETONES USING 2-HYDROXY-3-OXOACID SYNTHASE
07/31/2003WO2003062435A1 A method for generating engineered cells for locus specific gene regulation and analysis
07/31/2003WO2003062434A2 Transgenic tea plants obtained through microprojectile bombardment of leaf explants
07/31/2003WO2003062433A2 Element for the s-phase and meristem specific expression of genes in plants and use thereof
07/31/2003WO2003062432A1 Method for increasing the efficiency of an inhibitor of tyrosine kinase activity
1 ... 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 ... 4023